Latest News- Neuroendovascular Non-Coils Market: Neuroendovascular stents is expected to lead the Product Type segment during 2025-2029

The Neuroendovascular Non-Coils Market is being driven by Increasing incidence of intracranial aneurysms

The Neuroendovascular Non-Coils Market is expected to grow at a CAGR of 4.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 419.7 million. The neuroendovascular non-coils market is experiencing significant growth due to heightened awareness and education surrounding intracranial aneurysms and the available treatment alternatives. This increased knowledge among patients and healthcare providers results in increased demand for effective neuroendovascular solutions, such as non-coil devices. Early detection of intracranial aneurysms, facilitated by greater public awareness of symptoms, enables timely diagnosis and intervention. Consequently, patients are increasingly requesting advanced, minimally invasive procedures like flow diversion, leading to improved treatment outcomes and market expansion. 

Get more information on Neuroendovascular Non-Coils Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product Type
  • Neuroendovascular stents
  • Access devices
  • Flow diversion devices
  • Others
• End-user
  • Hospitals
  • Ambulatory surgical centers (ASCs)
  • Stroke centers
  • Others
• Application
  • Ischemic stroke
  • Arteriovenous malformation (AVM)
  • Aneurysm treatment
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing incidence of intracranial aneurysms
• Advancements in neuroendovascular non-coil technology
• Growing demand for minimally invasive treatment

However, the market also witnesses some limitations, which are as follows:

• Stringent regulations associated with approval of neuroendovascular non-coil devices
• Limitations and complications associated with flow diversion procedures
• Higher cost of neuroendovascular non-coil devices

Benefits of Buying Global Neuroendovascular Non-Coils Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Neuroendovascular Non-Coils Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Neuroendovascular Non-Coils market encompasses innovative neuroendovascular devices used in the treatment of cerebral aneurysms through embolization, a minimally invasive procedure. These devices, including stents, play a crucial role in cerebral aneurysm repair, preventing rupture. Specialists employ imaging for diagnosis and ensure safety through rigorous training and surgery recovery processes. Complications are managed, and effectiveness is maximized, making non-coils a vital tool in aneurysm treatment.

Market Research Overview

The Neuroendovascular Non-Coils market is a segment of the larger global healthcare supplies market, which encompasses businesses and research and development initiatives focused on medical consumables used for the diagnosis and treatment of neuroendovascular diseases. According to Technavio, the healthcare supplies market size is determined by the collective revenue generated by manufacturers of medical supplies, including neuroendovascular non-coils, syringes, drapes, gloves, and gowns. Factors driving market growth include the increasing global population aging, with nearly one-quarter of the US population projected to be over 60 years old by 2050, and Europe reaching a similar demographic milestone by 2030. This demographic shift will result in a higher prevalence of neuroendovascular diseases, necessitating increased demand for advanced diagnostic and treatment solutions, such as neuroendovascular non-coils.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/